The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Hypothyroidism and Atherosclerosis
Abstract
This autopsy finding of diffuse atherosclerosis in a 58-yrold woman was published as an appendix to William Ord’s classical description of the syndrome of myxedema. Soon thereafter, the hypothesis of a causal relationship between hypothyroidism and atherosclerosis was first raised in 1883 by E. Theodor Kocher (2), who noted that arteriosclerosis commonly occurred after thyroid extirpation. Since the time of the first associations between these two common disorders, hypothyroidism and atherosclerosis have subsequently been linked by a body of clinical case reports, epidemiological studies, and biochemical observations. The hypothesis of a relationship has subsequently been tested in case-control and cohort studies. Important associations have been identified among hypercholesterolemia, hypertension, and certain newer risk factors for atherosclerosis in individuals with overt hypothyroidism and, in some cases, subclinical hypothyroidism. There have also been clinical observations and trials describing the consequences of treating hypothyroidism in patients with ischemic heart disease and of revascularizing patients with ischemic heart disease who are hypothyroid. These studies are the subject of this commentary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
Danese, M. D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.2993 · Cited by 424
Meier, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4860 · Cited by 401
Acute Effects of Thyroid Hormone on Vascular Smooth Muscle
OJAMAA, K., KLEMPERER, J. D., & KLEIN, I. (1996) · Thyroid · doi:10.1089/thy.1996.6.505 · Cited by 342
Staub, J.-J., Althaus, B. U., Engler, H., Ryff, A. S., Trabucco, P., Marquardt, K., Burckhardt, D., Girard, J., & Weintraub, B. D. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90782-7 · Cited by 318
Caraccio, N. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1533 · Cited by 301
Thompson, G. R., Soutar, A. K., Spengel, F. A., Jadhav, A., Gavigan, S. J., & Myant, N. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2591 · Cited by 274
LDL/HDL‐CHANGES IN SUBCLINICAL HYPOTHYROIDISM: POSSIBLE RISK FACTORS FOR CORONARY HEART DISEASE
ALTHAUS, B. U., STAUB, J. ‐., LÈCHE, A. R., OBERHÄNSLI, A., & STÄHELIN, H. B. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03651.x · Cited by 246
Christ-Crain, M., Meier, C., Guglielmetti, M., Huber, P. R., Riesen, W., Staub, J.-J., & Müller, B. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00372-6 · Cited by 241
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“To the extent that the goal of treating hypothyroidism is to reverse the adverse effects of thyroid hormone deficiency on all body systems, inadequate therapy would be expected to be associated with the same comorbidities as untreated disease, especially dyslipidemia (81), atherosclerotic cardiovascular disease (237),…”
Self-citationThe Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729
Direct effects of thyroid hormones on hepatic lipid metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.10 · Cited by 660
Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects
Roos, A., Bakker, S. J. L., Links, T. P., Gans, R. O. B., & Wolffenbuttel, B. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1718 · Cited by 542
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
Thyroid Hormones and Cardiovascular Function and Diseases
Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.045 · Cited by 515
Hypothyroidism as a Risk Factor for Cardiovascular Disease
Biondi, B., & Klein, I. (2004) · Endocrine · doi:10.1385/endo:24:1:001 · Cited by 412
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350
Siegmann, E.-M., Müller, H. H. O., Luecke, C., Philipsen, A., Kornhuber, J., & Grömer, T. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0190 · Cited by 304
Nuclear Receptors and Their Selective Pharmacologic Modulators
Burris, T. P., Solt, L. A., Wang, Y., Crumbley, C., Banerjee, S., Griffett, K., Lundasen, T., Hughes, T., & Kojetin, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006833 · Cited by 283
Kvetny, J., Heldgaard, P. E., Bladbjerg, E. M., & Gram, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02088.x · Cited by 280
Thyroid hormone in health and disease
Boelaert, K., & Franklyn, J. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06131 · Cited by 282
Sinha, R. A., Bruinstroop, E., Singh, B. K., & Yen, P. M. (2019) · Thyroid · doi:10.1089/thy.2018.0664 · Cited by 271
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Thyroid hormone and blood pressure regulation
Danzi, S., & Klein, I. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0060-7 · Cited by 261
“Overt hypothyroidism is associated with accelerated atherosclerosis and coronary artery disease, possibly due to the higher incidence of hypercholesterolemia and diastolic hypertension [ 69 ].”
BackgroundThe Effect of Thyroid Disorders on Lipid Levels and Metabolism
Duntas, L. H., & Brenta, G. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.012 · Cited by 258
Somwaru, L. L., Arnold, A. M., Joshi, N., Fried, L. P., & Cappola, A. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1696 · Cited by 239
Self-citationThyroid Diseases and Cerebrovascular Disease
Squizzato, A., Gerdes, V. E. A., Brandjes, D. P. M., Büller, H. R., & Stam, J. (2005) · Stroke · doi:10.1161/01.str.0000181772.78492.07 · Cited by 236
Klein, I., & Danzi, S. (2016) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.04.002 · Cited by 218
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2208 · Cited by 215
Boekholdt, S. M., Titan, S. M., Wiersinga, W. M., Chatterjee, K., Basart, D. C. G., Luben, R., Wareham, N. J., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03640.x · Cited by 167
Roos, A., Linn-Rasker, S. P., van Domburg, R. T., Tijssen, J. P., & Berghout, A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1714 · Cited by 150
Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial
Bolk, N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.436 · Cited by 128
Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., Gunnell, D., & Vatten, L. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.855 · Cited by 125
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Subclinical thyroid dysfunction and blood pressure: a community‐based study
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02619.x · Cited by 117
Activation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.001 · Cited by 109
Åsvold, B. O., Bjøro, T., Platou, C., & Vatten, L. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04477.x · Cited by 107
Lee, Y. K., Kim, J. E., Oh, H. J., Park, K. S., Kim, S. K., Park, S. W., Kim, M. J., & Cho, Y. W. (2011) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2011.26.4.432 · Cited by 100
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
Chaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2255 · Cited by 92
Self-citationThyroid dysfunction in the elderly
Boelaert, K. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.30 · Cited by 84
Carswell, J. M., Gordon, J. H., Popovsky, E., Hale, A., & Brown, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3125 · Cited by 83
Is subclinical hypothyroidism a cardiovascular risk factor in the elderly?
Pasqualetti, G., Tognini, S., Polini, A., Caraccio, N., & Monzani, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3818 · Cited by 79
Fadeyev, V. V., Morgunova, T. B., Melnichenko, G. A., & Dedov, I. I. (2010) · Hormones · doi:10.14310/horm.2002.1274 · Cited by 77
“Elevated levels of total cholesterol, LDL cholesterol, and apolipoprotein B are well documented features of overt hypothyroidism.(11) These changes are reversible upon treatment.”
BackgroundRhee, C. M., Kim, S., Gillen, D. L., Oztan, T., Wang, J., Mehrotra, R., Kuttykrishnan, S., Nguyen, D. V., Brunelli, S. M., Kovesdy, C. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4311 · Cited by 67
Li, X., Wang, Y., Guan, Q., Zhao, J., & Gao, L. (2017) · Clinical Endocrinology · doi:10.1111/cen.13338 · Cited by 66
Boeving, A., Paz-Filho, G., Radominski, R. B., Graf, H., & de Carvalho, G. A. (2011) · Thyroid · doi:10.1089/thy.2010.0315 · Cited by 58
Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study
Marouli, E., Kus, A., Del Greco M, F., Chaker, L., Peeters, R., Teumer, A., Deloukas, P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa239 · Cited by 57
“Hashimoto’s thyroiditis and CAD risk In observational studies, both overt and subclinical hypothyroidism have been associated with an increased risk of atherosclerosis and adverse cardiovascular events, including CAD (3, 4, 42).”
BackgroundVigário, P. D. S., Vaisman, F., Coeli, C. M., Ward, L., Graf, H., Carvalho, G., Júnior, R. M., & Vaisman, M. (2013) · Endocrine · doi:10.1007/s12020-013-9886-1 · Cited by 54
Abdel-Moneim, A., Gaber, A. M., Gouda, S., Osama, A., Othman, S. I., & Allam, G. (2020) · Hormones · doi:10.1007/s42000-020-00208-8 · Cited by 45
Billon, C., Canaple, L., Fleury, S., Deloire, A., Beylot, M., Dombrowicz, D., del Carmine, P., Samarut, J., & Gauthier, K. (2014) · Endocrinology · doi:10.1210/en.2014-1098 · Cited by 45
“Human observation studies suggested that patients with overt hypothyroidism display an increased incidence of CVD and coronary atherosclerosis (10), findings that are now supported by metaanalyses (11, 12).”
BackgroundCardiovascular risk in elderly hypothyroid patients
Mariotti, S., & Cambuli, V. M. (2007) · Thyroid · doi:10.1089/thy.2007.0130 · Cited by 44
“After the first demonstration by an autoptic case-control study (21) of a greater prevalence and severity of atherosclerosis in 25 patients with myxedema, several subsequent studies confirmed these findings (22).”
InfluentialMice lacking the thyrotropin-releasing hormone gene: what do they tell us?
Yamada, M., Satoh, T., & Mori, M. (2003) · Thyroid · doi:10.1089/10507250360731505 · Cited by 42
Kaminski, J., Miasaki, F. Y., Paz-Filho, G., Graf, H., & Carvalho, G. A. D. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000192 · Cited by 42
Oliviero, U., Cittadini, A., Bosso, G., Cerbone, M., Valvano, A., Capalbo, D., Apuzzi, V., Calabrese, F., Lettiero, T., & Salerno, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0674 · Cited by 27
Metadata
- Authors
- Cappola, A. R., & Ladenson, P. W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2438-2444
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2091655302
- Cited by
- 640
- References
- 70
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.